Literature DB >> 16735376

Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.

Anastasia Nijnik1, Helen Ferry, Graham Lewis, Eleni Rapsomaniki, Janson C H Leung, Angelika Daser, Teresa Lambe, Christopher C Goodnow, Richard J Cornall.   

Abstract

The MRL-lpr/lpr mouse strain is a commonly used model of the human autoimmune disease systemic lupus erythematosus (SLE). Although much is known about the contribution of the lpr Fas mutation to B cell tolerance breakdown, the role of the genetic background of the MRL strain itself is less well explored. In this study, we use the MD4 anti-hen egg lysozyme Ig (IgHEL) transgenic system to explore B cell function in MRL+/+ and non-autoimmune mice. We demonstrate that MRL IgHEL B cells show spontaneous hyperactivity in the absence of self-antigen, which is associated with low total B cell numbers but an expansion of the marginal zone B cell population. However, B cell anergy is normal in the presence of soluble lysozyme [soluble hen egg lysozyme (sHEL)], and MRL IgHEL B cells undergo normal elimination in the presence of sHEL when competing with a polyclonal C57BL/6 B cell repertoire. We conclude that B cell hyperactivity may contribute to the autoimmune phenotype of MRL+/+ and MRL-lpr/lpr strains when it initiates antibody responses to rare or sequestered antigens that are below the threshold for tolerance induction, but that there is no B cell intrinsic defect in anergy in MRL mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735376     DOI: 10.1093/intimm/dxl047

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  12 in total

1.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

Review 2.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 3.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus.

Authors:  Tianfu Wu; Xiangmei Qin; Zoran Kurepa; Kirthi Raman Kumar; Kui Liu; Hasna Kanta; Xin J Zhou; Anne B Satterthwaite; Laurie S Davis; Chandra Mohan
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

5.  A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.

Authors:  Hisashi Oishi; Takahito Tsubaki; Tatsuhiko Miyazaki; Masao Ono; Masato Nose; Satoru Takahashi
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

Review 6.  Lymphoproliferative disorders involving T helper effector cells with defective LAT signalosomes.

Authors:  Romain Roncagalli; Michael Mingueneau; Claude Grégoire; Christelle Langlet; Bernard Malissen; Marie Malissen
Journal:  Semin Immunopathol       Date:  2010-01-28       Impact factor: 9.623

7.  C1q deficiency promotes the production of transgenic-derived IgM and IgG3 autoantibodies in anti-DNA knock-in transgenic mice.

Authors:  Liliane Fossati-Jimack; Josefina Cortes-Hernandez; Peter J Norsworthy; Mark J Walport; H Terence Cook; Marina Botto
Journal:  Mol Immunol       Date:  2007-08-01       Impact factor: 4.407

8.  Prevention of immune nephritis by the small molecular weight immunomodulator iguratimod in MRL/lpr mice.

Authors:  Qingran Yan; Fang Du; Xinfang Huang; Qiong Fu; Sheng Chen; Dai Dai; Chunde Bao
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

9.  BAFF and MyD88 signals promote a lupuslike disease independent of T cells.

Authors:  Joanna R Groom; Carrie A Fletcher; Stacey N Walters; Shane T Grey; Sally V Watt; Mathew J Sweet; Mark J Smyth; Charles R Mackay; Fabienne Mackay
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

10.  MRL Strains Have a BAFFR Mutation without Functional Consequence.

Authors:  Windy R Allman; Lunhua Liu; Adam S Coleman; Mustafa Akkoyunlu
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.